Neuralink raises $650M Series E for implantable brain-computer interfaces
Summary
Neuralink, Elon Musk's brain-computer interface company, raised $650 million in Series E funding at a $9 billion valuation. The round was reported by Semafor and included participation from ARK Invest, DFJ Growth, Founders Fund, G42, Sequoia Capital, Thrive Capital, and others. The funds will advance clinical development of its N1 implant, which uses robot-inserted penetrating threads to enable high-bandwidth neural communication for patients with paralysis and other neurological conditions.
Why it matters
This mega-round cements Neuralink's position as the most capitalized BCI company globally and reflects surging investor confidence in implantable neurotechnology. With 21 patients enrolled by early 2026, the funding accelerates the path toward high-volume manufacturing and automated surgical insertion, potentially transforming treatment for paralysis, blindness, and other neurological disorders.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial